Listen Live

Current Weather

Loading advertisement…

US FDA approves MannKind’s inhaled insulin for children

May 29 (Reuters) - The U.S. Food and Drug Administration has approved expanded use of MannKind's inhaled rapid-acting insulin in children with diabetes, offering patients under 18 years of age a needle-free treatment option, the company said on Friday. Shares of the company were up... Read More.